Gonadrotropin-releasing hormone agonists and fracture risk: A claims-based cohort study of men with nonmetastatic prostate cancer | Abt Associates

Skip to main content

This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Gonadrotropin-releasing hormone agonists and fracture risk: A claims-based cohort study of men with nonmetastatic prostate cancer

Smith MR, Lee WC, Brandman J, Wang Q, Botteman M, Pashos CL

Article

November 1, 2005